MLYS — MINERALYS THERAPEUTICS INC

Ownership history in 22NW, LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which 22NW, LP reported a position in MINERALYS THERAPEUTICS INC (MLYS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.4% (2025 Q3)
Avg. % of fund
5.39%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 358,325 — 0% 5.47% $13.0M $36.29
2025 Q3 REDUCED 358,325 -201,717 -36.0% 6.40% $13.6M $37.92
2025 Q2 ADDED 560,042 +98,698 +21.4% 4.77% $7.6M $13.53
2025 Q1 INITIATED 461,344 — — 4.91% $7.3M $15.88
% of Fund (quarterly)    MLYS price (monthly, adj. close)

Other funds also holding MLYS

As of 2025 Q4 — sorted by position size

Catalys Pacific, LLC 92.37% Andera Partners 32.71% Samsara BioCapital, LLC 3Y 7Y 21.98% Caligan Partners LP 3Y 8.28% SR ONE CAPITAL MANAGEMENT, LP 3Y 8.03% Caligan Partners LP 3Y 6.87% Buckley Capital Advisors, LLC 4.45% Velan Capital Investment Management LP 3Y 3.18% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 3.15% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 2.72%
← Back to 22NW, LP Holdings